期刊文献+

静脉注射胺碘酮治疗术后心衰伴室性心律失常的疗效观察 被引量:4

Clinical Efficacy of Intravenous Administration of Amiodarone in the Treatment of Postoperative Heart Failure Combined with Ventricular Tachycardia
原文传递
导出
摘要 目的:观察静脉注射胺碘酮对术后心衰伴室性心律失常患者的疗效。方法:选择术后心衰并有室性心动过速、多源性室性早搏的患者42例,经利多卡因治疗无效,胺碘酮150mg稀释后静脉滴注约30min后,再给以胺碘酮0.5~1mg·min-1维持,24h总量为1000~1200mg。每小时记录用药前后心律、心率、血压及心衰症状等,观察24h。结果:治疗后患者显效17例(40%)、有效20例(47%)、无效5例(12%),治疗前、后差异有统计学意义(P<0.05)。用药后心功能改善情况,差异有统计学意义(P<0.05)。结论:静脉注射胺碘酮治疗术后心衰伴室性心律失常有效,对心功能改善有益。 OBJECTIVE:To observe the effect of intravenous administration of amiodarone on postoperative heart failure and ventricular arrhythmia.METHODS:A total of 42 postoperative heart failure patients with ventricular tachycardia and multi-source ventricular premature beat were treated with lidocaine,but clinical efficacy was not obtained.Those patients received intravenous administration of diluted amiodarome 150 mg.After 30 minutes the dose of amiodarone was kept at 0.5~1.0 mg·min-1,and the total dosage ranged from 1 000 mg to 1 200 mg within 24 h.Clinical symptoms were recorded in every hour,such as cardiac rhythm,heart rate,blood pressure,heart failure.RESULTS:After 24 h of treatment,17 cases of ventricular arrhythmia had apparent effect(40%),20 cases of partial effect(47%),5 cases of no effect(12%),there were statistical significance in difference before and after treatment(P0.05).The improvement of heart function was significantly different before and after treatment(P0.05).CONCLUSION:Intravenous administration of amiodarone has effect on postoperative heart failure and ventricular arrhythmia,and is beneficial to the improvement of cardiac function.
出处 《中国药房》 CAS CSCD 北大核心 2010年第24期2235-2236,共2页 China Pharmacy
关键词 胺碘酮 室速 室早 心衰 治疗 Amiodarone Ventricular tachycardia Ventricular premature beat Heart failure Treatment
  • 相关文献

参考文献8

  • 1The Cardiac Arrhythmia Suppression Trial Ⅱ Investigators. Effect of the antiarrhythmic agent moricizine on survival after myocardial infarction[J]. N Engl J Med, 1992, 327 (4):227.
  • 2郭林妮,黄元铸,蒋文平,李庚山,陆再英,戚文航,任自文,吴宁,向晋涛,朱俊,方圻,高润霖.胺碘酮抗心律失常治疗应用指南[J].中国心脏起搏与心电生理杂志,2004,18(6):401-407. 被引量:392
  • 3Tasta A, Ojetti V, Migneco A, et al. Use of amiodarone in emergency[J], Eur Rev Med Pharmacol Sci, 2005, 9 (3):183.
  • 4Ful~moto Y, Yamada A, Ando H, et al. Fatal case of amiodarone-induced acute respiratory distress syndrome in a patient with severe left ventricular dysfunction due to extensive anterior acute myocardial infarction[J]. Fukuoka Igaku Zasshi, 2006,97 (2) : 37.
  • 5Singh BN. Significance and control of cardiac arrhythmias in patiems with congestive cardiac failure[J]. Heart Fail Rev, 2002,7 (3) : 285.
  • 6Satomi K, Kurita T, Takatsuki S, et al. Amiodarone therapy in patients implanted with cardioverter-defibrillator for life-threatening ventricular arrhythmias[J]. Circ J, 2006,70(8) : 977.
  • 7木胡牙提,程祖亨,马依彤,布艾加尔,张爱伦,汤宝鹏.静脉应用胺碘酮治疗充血性心力衰竭并发的室性心动过速[J].中华心律失常学杂志,2002,6(2):78-79. 被引量:7
  • 8张淑丽,吴贤尧,王淑惠,姜秋兰,姜珉,王军.胺碘酮对合并于充血性心力衰竭的室性心律失常疗效观察[J].中华心律失常学杂志,2002,6(2):100-101. 被引量:18

二级参考文献13

  • 1Gonzalez ER,Kannewurf BS,Ornato JP.Intravenous amiodarone for ventricular arrhythmias:overview and clinical use.Resuscitation,1998,39:33-42.
  • 2Junga G,Duru F,Candinas R.Heart failure and treatment of ventricular arrhythmias.Schweiz Rundsch Med Prax,1999,88:215-222.
  • 3Scheiman MM,Levine JH,Cannom DS,et al.Dine-Ranging study of intravenous amiodarone in patients with life-threatening ventricular tachyarrhythmias.Circulation,1995,92:3264-3272.
  • 4Schmidt A,Konig W,Binner L,et al.Efficacy and safety of intravenous amiodarone in acute refractory arrhythmias.Clin Cardiol,1988,11:481-485.
  • 5Wioson JS,Podrid PJ.Side effects from amiodarone.Am Heart J,1991,121:158.
  • 6Antman EM, Anbe DT, Armstrong PW,et al.ACC/AHA guidlines for the management of patients with ST-elevation myocardial infarction-executive summary[J]. Circulation,2004,110:588
  • 7Hammill SC.Cardiac arrhythmias[J].JACC,2004,44(suppl 2):16A
  • 8Goldschlager N, Epstein AE, Naccarelli G, et al. Practical guidelines for clinicians who treat patients with amiodarone. Practice Guidelines Subcommittee, North American Society of Pacing and Electrophysiology[J]. Arch Intern Med,2000,160:1 741
  • 9The American Heart Association in Collaboration with the International Liais on Committee on Resuscitation. Guidelines 2000 for cardiopulmonary resuscitation and emergency cardiovascular care. Part 6: Advance cardiovascular life support. Section 5: Phamacology I: Agents for Arrhythmias[J]. Circulation, 2000, 102(Suppl 8): I 112
  • 10Fuster V, Rydén LE, Asinger RW, et al. ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation[J]. Eur Heart J,2001,22:1 852

共引文献413

同被引文献21

引证文献4

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部